Catalyst Wire Dossier Catalyst Wire Dossier

Ravagalimab

ravagalimab · AbbVie
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ravagalimab, covering 2023-03-15 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of a Ravagalimab Subcutaneous Formulation in a Pre-Filled Syringe [Phase 1]

See pricing